233 related articles for article (PubMed ID: 18310733)
1. Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection.
Stewart CM; Berg KM; Cha S; Reeves WH
J Am Dent Assoc; 2008 Mar; 139(3):291-9; quiz 358-9. PubMed ID: 18310733
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in patients with primary Sjögren's syndrome and xerostomia: a comparative study.
Rostron J; Rogers S; Longman L; Kaney S; Field EA
Gerodontology; 2002 Jul; 19(1):53-9. PubMed ID: 12164241
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in patients with Sjögren's syndrome and sicca complex.
López-Jornet P; Camacho-Alonso F
J Oral Rehabil; 2008 Dec; 35(12):875-81. PubMed ID: 18976259
[TBL] [Abstract][Full Text] [Related]
4. Impact of Sjögren's syndrome on oral health-related quality of life in southern Chinese.
McMillan AS; Leung KC; Leung WK; Wong MC; Lau CS; Mok TM
J Oral Rehabil; 2004 Jul; 31(7):653-9. PubMed ID: 15210025
[TBL] [Abstract][Full Text] [Related]
5. Oral distress in primary Sjögren's syndrome: implications for health-related quality of life.
Enger TB; Palm Ø; Garen T; Sandvik L; Jensen JL
Eur J Oral Sci; 2011 Dec; 119(6):474-80. PubMed ID: 22112034
[TBL] [Abstract][Full Text] [Related]
6. Validation of Oral Health Impact Profile-14 and its association with Hypossialia in a Sjögren Syndrome Portuguese Population.
Amaral J; Sanches C; Marques D; Vaz Patto J; Barcelos F; Mata A
Acta Reumatol Port; 2018; 43(2):137-145. PubMed ID: 30091957
[TBL] [Abstract][Full Text] [Related]
7. Oral symptoms and oral function in people with Sjögren's syndrome.
Epstein JB; Villines DC; Sroussi HY
Clin Exp Rheumatol; 2015; 33(1):132-3. PubMed ID: 25572418
[No Abstract] [Full Text] [Related]
8. Elucidating the role of hyposalivation and autoimmunity in oral candidiasis.
Billings M; Dye BA; Iafolla T; Grisius M; Alevizos I
Oral Dis; 2017 Apr; 23(3):387-394. PubMed ID: 27998016
[TBL] [Abstract][Full Text] [Related]
9. Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.
Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Yves Hatron P; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Saliou P; Pers JO; Seror R; Saraux A
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):528-535. PubMed ID: 27390310
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
Jensen SB; Vissink A
Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
[TBL] [Abstract][Full Text] [Related]
11. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of implementing the OHIP-14 questionnaire to assess the impact of xerostomia and hyposalivation on quality of life in patients with primary Sjögren's syndrome.
Serrano J; López-Pintor RM; Fernández-Castro M; Ramírez L; Sanz M; López J; Blázquez MÁ; González JJ; Hernández G;
J Oral Pathol Med; 2022 Oct; 51(9):810-817. PubMed ID: 35998227
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of changes in oral health-related quality of life over time in patients with Sjögren's syndrome.
Azuma N; Katada Y; Yoshikawa T; Yokoyama Y; Nishioka A; Sekiguchi M; Kitano M; Kitano S; Sano H; Matsui K
Mod Rheumatol; 2021 May; 31(3):669-677. PubMed ID: 32657185
[TBL] [Abstract][Full Text] [Related]
14. Psychological status and disease activity were major predictors of body image disturbances in patients with Sjögren's syndrome.
Li Z; Wang Y; Dong C; Guo J; Fu T; Li L; Gu Z
Psychol Health Med; 2020 Jun; 25(5):572-582. PubMed ID: 31370688
[TBL] [Abstract][Full Text] [Related]
15. Oral health-related quality of life in primary Sjögren's syndrome.
Fernández-Martínez G; Zamora-Legoff V; Hernández Molina G
Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):92-96. PubMed ID: 29754950
[TBL] [Abstract][Full Text] [Related]
16. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology.
Cho MA; Ko JY; Kim YK; Kho HS
J Oral Rehabil; 2010 Mar; 37(3):185-93. PubMed ID: 20002531
[TBL] [Abstract][Full Text] [Related]
17. Salivary and serum B-cell activating factor (BAFF) levels after hydroxychloroquine treatment in primary Sjögren's syndrome.
Mumcu G; Biçakçigil M; Yilmaz N; Ozay H; Karaçayli U; Cimilli H; Yavuz S
Oral Health Prev Dent; 2013; 11(3):229-34. PubMed ID: 23878841
[TBL] [Abstract][Full Text] [Related]
18. Sjögren syndrome: reduced quality of life as an oral-systemic consequence.
Iacopino AM
J Can Dent Assoc; 2010; 76():a98. PubMed ID: 20719102
[No Abstract] [Full Text] [Related]
19. Dental and periodontal status of Sjögren's syndrome.
Boutsi EA; Paikos S; Dafni UG; Moutsopoulos HM; Skopouli FN
J Clin Periodontol; 2000 Apr; 27(4):231-5. PubMed ID: 10783835
[TBL] [Abstract][Full Text] [Related]
20. Impaired functional status in primary Sjögren's syndrome.
Hackett KL; Newton JL; Frith J; Elliott C; Lendrem D; Foggo H; Edgar S; Mitchell S; Ng WF
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1760-4. PubMed ID: 23111856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
